MindBody acquires dynamic pricing technology company
Business management software company MindBody, based in San Luis Obispo, announced March 29 that it had acquired early-stage Southern California yield management company Lymber Wellness. Lymber uses MindBody’s application program interface platform to support adjustable pricing strategies for wellness-based businesses. The technology changes the prices for classes and appointments based on availability, similar to dynamic Read More →
Limoneira shareholders approve request to increase number of shares
Limoneira shareholders approved a board of directors request to increase its number of authorized shares March 28, but the company has no plans to issue additional stock this year, said CEO Harold Edwards. More than 100 shareholders gathered at the Ventura County Agriculture Museum in Santa Paula for the annual meeting to confirm three new Read More →
Pacific Premier shareholders approve acquisition of Heritage Oaks
Pacific Premier Bancorp shareholders have voted to approve the acquisition of Paso Robles-based Heritage Oaks Bancorp, Pacific Premier said March 28. The all-stock deal, announced Dec. 13, is valued at $405.6 million or $11.68 per share. It combines the region’s largest bank, with $2 billion in assets, and Pacific Premier, which has $3.8 billion in assets, Read More →
PathPoint CEO Cynthia Burton retiring
After 23 years as president and CEO, Cynthia Burton announced March 27 that she will retire from PathPoint in the summer of 2017. Burton spent seven years with organization, which provides training and support services to people with disadvantages or disabilities, before assuming the role of CEO in 1994. Since then, PathPoint has expanded to Read More →
Law firm probing Sientra board of directors
The law firm of Brodsky & Smith has announced an investigation into the board of directors at Sientra, a breast implant manufacturing firm based in Goleta. According to a news release from the law firm, the investigation comes after previous litigation. The complaint alleges that the defendants made false and misleading statements, including failing to Read More →
500 Amgen employees to be re-assigned, relocated or laid off
Nearly 500 Amgen employees in Thousand Oaks have been notified that they will be re-assigned, relocated or laid off as part of a restructuring plan. The biotech giant informed employees on March 22 that they will be reassigned to a new Tampa Bay, Fla. facility and research and development offices in Cambridge, Mass. and South Read More →
Amgen gets European approval for biosimilar of Humira
Thousand Oaks-based Amgen has announced that the European Commission has granted marketing authorization for Amgevita, a drug that treats inflammatory diseases, including moderate-to-severe rheumatoid arthritis. The Amgen biosimilar will compete with AbbVie’s blockbuster drug Humira. “The approval of our first biosimilar by the European Commission is a major milestone not just for Amgen as a company, but for the millions Read More →
